The Hepatitis C Transplant Collaborative
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
| Condition(s) | Transplant; Failure, Heart, Hepatitis C |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable. |
| Who can participate | Inclusion Criteria: 1. Recipient of a proven HCV NAT+ donor heart. 2. Re-transplant patients will be included. Exclusion Criteria: 1\. Multi-organ transplantation |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Baylor Research Institute |
| Locations | Dallas, Texas, United States |
| Start date | 2019-09-16 |
| NCT ID | NCT04493385 |
| Official listing | https://clinicaltrials.gov/study/NCT04493385 |